Showing results (2031-2040 of 2,589) with videos related to

Sort By:
Pageof 259
Molecular Oncology|August 21, 2023
Lasting response by vertical inhibition with cetuximab and trametinib in KRAS-mutated colorectal cancer patient-derived xenograftsTimm M Reissig, Swetlana Ladigan-Badura, Anja Steinberg, et al.
Molecular Oncology|July 31, 2023
High-content screening of drug combinations of an mPGES-1 inhibitor in multicellular tumor spheroids leads to mechanistic insights into neuroblastoma chemoresistanceAhlem Zaghmi, Erdem Aybay, Long Jiang, et al.
Molecular Oncology|October 27, 2023
Identification of pathogenic germline variants in a large Chinese lung cancer cohort by clinical sequencingZhe Yu, Zirui Zhang, Jun Liu, et al.
Molecular Oncology|October 21, 2023
NOTCH1 and CREBBP co-mutations negatively affect the benefit of adjuvant therapy in completely resected EGFR-mutated NSCLC: translational research of phase III IMPACT studySatoshi Ikeda, Masahiro Tsuboi, Kazuko Sakai, et al.
Molecular Oncology|October 24, 2023
Hepsin promotes breast tumor growth signaling via the TGFβ-EGFR axisDenis Belitškin, Pauliina Munne, Shishir M Pant, et al.
Molecular Oncology|July 7, 2023
SETD2 loss in renal epithelial cells drives epithelial-to-mesenchymal transition in a TGF-β-independent mannerTianchu Wang, Ryan T Wagner, Ryan A Hlady, et al.
Molecular Oncology|July 6, 2023
Ex vivo mapping of enhancer networks that define the transcriptional program driving melanoma metastasisVeronica Manicardi, Mila Gugnoni, Elisabetta Sauta, et al.
Molecular Oncology|June 26, 2023
Functional inhibition of the RNA-binding protein HuR sensitizes triple-negative breast cancer to chemotherapyLanjing Wei, Qi Zhang, Cuncong Zhong, et al.
Molecular Oncology|July 26, 2023
Epigenetic silencing of HTATIP2 in glioblastoma contributes to treatment resistance by enhancing nuclear translocation of the DNA repair protein MPGThi Tham Nguyen, Premnath Rajakannu, Minh Diêu Thanh Pham, et al.
Molecular Oncology|July 28, 2023
Activation of the EGFR/PI3K/AKT pathway limits the efficacy of trametinib treatment in head and neck cancerOfra Novoplansky, Avital B Shnerb, Divyasree Marripati, et al.
Pageof 259